GRAIL Announces FDA Advisory Committee Meeting to Review Premarket Approval Application for the Galleri® Multi-Cancer Early Detection Test

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/20/2026

1. SPY
2. XENE
3. NUE
4. HUBS
5. RTB
6. ONON
7. AAPL
8. TRMD
9. ACN
10. AZN

Go back to GRAIL Announces FDA Advisory Committee Meeting to Review Premarket Approval Application for the Galleri® Multi-Cancer Early Detection Test
(NASDAQ: GRAL) Delayed: 80.77 +0.82 (1.03%)
Previous Close $79.95    52 Week High $ 
Open $81.48    52 Week Low $ 
Day High $82.85    P/E N/A 
Day Low $78.20    EPS $ 
Volume 3,003,825